Corundum Neuroscience appoints head of business development

Corundum Neuroscience (CNS), a neuroscience venture builder and fund launched in September 2023, has appointed Itsik Francis as head of business development as the company expands its portfolio of neurotech ventures and strategic partnerships. Dr Francis brings more than 15 years’ experience in investment and business development in medtech and biotech, and most recently was principal at OurCrowd where he contributed to the launch of the Global Health Equity Fund in partnership with the WHO Foundation. He holds a PhD in medical molecular biology from University College London, UK.

CNS announced the appointment on 28 January 2025.